Related Experiment Video

Updated: Dec 18, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.3K

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2

Changhua Yi1,2, Yongxiang Yi3,4, Junwei Li5

  • 1Department of Infectious Diseases, The Second Hospital of Nanjing, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210003, China.

Virologica Sinica
|June 12, 2020
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.3K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.3K

Related Experiment Videos

Last Updated: Dec 18, 2025

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.3K
Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

2.3K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.3K

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

820
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
820
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.0K

Articles linked to this work by shared authors, journal, and citation graph.

Analysis of Risk Factors and Development of a Predictive Nomogram for Bronchiolitis Obliterans in Children With Severe Adenovirus Pneumonia: A Retrospective Study.

Canadian respiratory journal·2026

Biosample Donation Intentions of Patients with Infectious Disease Based on the Theory of Planned Behavior: A Qualitative Study.

Infection and drug resistance·2026

Machine learning of immune-related laboratory indicators enables discrimination between pulmonary and extrapulmonary tuberculosis.

Frontiers in medicine·2026

Intratumoral microbial heterogeneity in HCC reveals a potential therapeutic target.

JHEP reports : innovation in hepatology·2025

Baicalein Induces Hepatic Stellate Cell Senescence and Attenuates Liver Fibrosis via CEBPZ/p53/HK2-Mediated Glycolysis Inhibition.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2025

Host Immune Response to Respiratory Syncytial Virus Infection in Children.

Influenza and other respiratory viruses·2025

First insight into the virome composition of the vulnerable Naemorhedus griseus.

Virologica Sinica·2026

Enteroviruses Antagonize the Host Restriction Factor ABL2 via Proteasomal Degradation to Facilitate Viral Replication.

Virologica Sinica·2026

Identification and characterization of anti-chikungunya virus compounds using a biosafe toolkit.

Virologica Sinica·2026

Pre-existing hemagglutinin-specific antibody levels are associated with B-cell repertoire maturation and antibody breadth after influenza vaccination.

Virologica Sinica·2026

SARS-CoV-2 3CLpro inhibits the replication of influenza viruses through the cleavage of NP and PA.

Virologica Sinica·2026

Stabilization of prefusion hMPV F improves manufacturability and protective immunity across hMPV lineages.

Virologica Sinica·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us